New study tests drug to help PAD patients walk farther
NCT ID NCT06319339
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 31 times
Summary
This study tests whether a single dose of the drug diroximel fumarate (Vumerity) can improve blood vessel function and walking ability in people with peripheral artery disease (PAD). PAD causes leg pain during walking due to poor blood flow. Researchers will give 20 participants either the drug or a placebo and measure changes in blood flow, oxygen use, and treadmill walking distance. The goal is to see if reducing oxidative stress can ease symptoms and improve mobility.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Nebraska - Omaha
RECRUITINGOmaha, Nebraska, 68182, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.